Advertisement

Topics

Advanced Cardiac Therapeutics Company Profile

12:33 EDT 26th September 2017 | BioPortfolio

Headquartered in Laguna Beach, California, USA, ACT specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology based on microwave radiometry.


News Articles [2886 Associated News Articles listed on BioPortfolio]

Researchers investigate the potential of spider silk protein for engineering artificial heart

Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart. The main cause of reduced cardiac functionality lies in the ir...

ACLS during transport not linked to increased survival for patients with out-of-hospital cardiac arrest

There is no association between prehospital advanced cardiac life support (ACLS) and survival to hospital discharge in patients suffering from out-of-hospital cardiac arrest (OHCA).

GI Bleeding in Cirrhosis Patients With CAD and Cardiac Stents

Cirrhotic patients often have varices and coagulopathy. Is it safe to treat these patients with dual antiplatelet therapy after cardiac stenting? Alimentary Pharmacology & Therapeutics

Advanced Proteome Therapeutics Corporation Announces Rights Offering

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/01/17 -- Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) is pleased to announce that it wi...

Advanced Proteome Therapeutics Corporation Completes Rights Offering for Gross Proceeds of ...

VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 11, 2017) -Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to report that it has Re...

Spider silk protein may be useful for engineering artificial cardiac tissue

Ever more people are suffering from cardiac insufficiency. The main cause of reduced cardiac functionality lies in the irreversible loss of cardiac muscle cells due to disease, especially ischemic dis...

Patients undergoing out-of-hospital cardiac arrest do not benefit from ACLS during transport

(Society for Academic Emergency Medicine) There is no association between prehospital advanced cardiac life support (ACLS) and survival to hospital discharge in patients suffering from out-of-hospita...

Lower survival rate: Patients with advanced cancer who suffer cardiac arrest in hospital

Patients with advanced cancer who suffer cardiac arrest in the hospital have a survival rate of less than 10 percent--half the rate of other patients without cancer, according to a nationwide study le...

PubMed Articles [3861 Associated PubMed Articles listed on BioPortfolio]

The Introduction and Clinical Use of Cardiac-Specific Troponin Assays.

The earliest biomarkers introduced to diagnose myocardial infarction (MI) such as aspartate aminotransferase (AST) and lactic dehydrogenase (LDH) lacked cardiac specificity and were replaced by creati...

Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.

The soluble receptor for advanced glycation end products (sRAGE) has been implicated in diabetic vascular complications. We have examined the association between sRAGE and cardiac markers [NT-proBNP a...

Extensive atrial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance associated with advanced interatrial block electrocardiogram pattern.

Patterns of Resuscitation Care and Survival After In-Hospital Cardiac Arrest in Patients With Advanced Cancer.

Little is known regarding patterns of resuscitation care in patients with advanced cancer who suffer in-hospital cardiac arrest (IHCA).

Effect of prehospital advanced airway management for pediatric out-of-hospital cardiac arrest.

Respiratory care may be important in pediatric out-of-hospital cardiac arrest (OHCA) due to the asphyxial nature of the majority of events. However, evidence of the effect of prehospital advanced airw...

Clinical Trials [6480 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Smartphone Video-assisted Advanced Life Support of Patients With Out-of-hospital Cardiac Arrest by EMS Under Physician Direction

Direct medical control using video conferencing capabilities of smartphones has never been conducted in out-of-hospital cardiac arrest patients. This study was conducted to investigate its...

Companies [2203 Associated Companies listed on BioPortfolio]

Advanced Cardiac Therapeutics, Inc.

Headquartered in Laguna Beach, Calif., privately held Advanced Cardiac Therapeutics, Inc. specializes in advanced irrigated cardiac catheter ablation systems with proprietary temp...

Advanced Cardiac Therapeutics

Headquartered in Laguna Beach, California, USA, ACT specializes in advanced irrigated cardiac catheter ablation systems with proprietary temperature-sensing technology based on microwave radiometr...

Cardiac Insight, Inc.

Cardiac Insight, Inc. (www.cardiacinsightinc.com) is a U.S. developer of advanced body-worn digital health care information devices for cardiology, respiratory and other complex ...

Medicomp, Inc.

Medicomp, Inc., founded in 1981, designs, develops and provides advanced cardiac monitoring products and services using the most sophisticated and reliable ambulatory heart-monitoring systems availabl...

Myogen

Research and development of therapeutics based on signaling pathways in cardiac, hypertrophy, myosin heavy chain research and gene/protein expression profiling using its human cardiac tissue bank.

More Information about "Advanced Cardiac Therapeutics" on BioPortfolio

We have published hundreds of Advanced Cardiac Therapeutics news stories on BioPortfolio along with dozens of Advanced Cardiac Therapeutics Clinical Trials and PubMed Articles about Advanced Cardiac Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Advanced Cardiac Therapeutics Companies in our database. You can also find out about relevant Advanced Cardiac Therapeutics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record